Entera Bio (ENTX) Payables (2017 - 2026)
Entera Bio's Payables was $575,000 in Q2 2026, up 50.1% from $383,000 a year earlier and up 109.9% from the prior quarter.
Powered by 
Analysis
Entera Bio (ENTX) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Payables at Entera Bio came in at $448,000, up 239.4% from FY2024.
- Payables has now increased for three consecutive years, with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- In earlier years, Payables was $132,000 in FY2024 (+59.0%), $83,000 in FY2023 (+388.2%), $17,000 in FY2022 (-89.8%) and $166,000 in FY2021 (+1.2%).
- The Q2 2026 figure marks the highest quarterly Payables since Q2 2021.
- Compared with a year earlier, Payables has increased for seven straight quarters, with growth averaging 120.1% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q2 2025 (growth of 455.1%); the worst was Q2 2022 (a decline of 92.6%).
- Per Business Quant data, ENTX's Payables in the three quarters before Q2 2026 was $274,000 (Q1 2026), $448,000 (Q4 2025) and $216,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Entera Bio | 563.51 Mn | 269.58 Mn | - | 406,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 406,000.00 |
| Jun 30, 2026 | 575,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 216,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 413,000.00 |
| Jun 30, 2022 | 109,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 166,000.00 |
API Access
Entera Bio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ENTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();